These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6882910)

  • 1. [Protective effect of allopurinol during chemotherapy with 5-fluorouracil of mouse blast leukemia].
    Bukhman VM; Mamedov FF
    Biull Eksp Biol Med; 1983 Aug; 96(8):84-6. PubMed ID: 6882910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy of leukemia La with Damvar and cytostatics.
    Pujman V; Cernochová S
    Neoplasma; 1979; 26(1):85-8. PubMed ID: 431759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
    Lindnér P; Carlsson G; Gustavsson B; Holmberg SB; Naredi P; Peterson A; Hafström L
    Anticancer Res; 1994; 14(3A):847-52. PubMed ID: 8074485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro.
    Schwartz PM; Handschumacher RE
    Cancer Res; 1979 Aug; 39(8):3095-101. PubMed ID: 455294
    [No Abstract]   [Full Text] [Related]  

  • 5. Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts.
    Houghton JA; Houghton PJ
    Cancer Treat Rep; 1982 May; 66(5):1201-6. PubMed ID: 7083222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal injection of dipyridamole increases the life span of tumor bearing mice treated with fluorouracil.
    Barberl-Heyob M; Merlin JL; Weber B
    In Vivo; 1992; 6(5):535-40. PubMed ID: 1457748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule.
    Campbell TN; Howell SB; Pfeifle C; House BA
    Cancer Treat Rep; 1982 Sep; 66(9):1723-7. PubMed ID: 7116349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil treatment of rat leukemia and a reappraisal of its application in human leukemia.
    Ermens AA; Kroes AC; Lindemans J; Abels J
    Anticancer Res; 1986; 6(4):797-800. PubMed ID: 3752959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer.
    Kroener JF; Saleh F; Howell SB
    Cancer Treat Rep; 1982 May; 66(5):1133-7. PubMed ID: 7083215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis.
    Yokomizo H; Yoshimatsu K; Hashimoto M; Ishibashi K; Umehara A; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Anticancer Res; 2004; 24(2C):1131-4. PubMed ID: 15154636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reduction of 5-fluorouracil toxicity with allopurinol].
    Garin AM; Mamedov FF
    Vestn Akad Med Nauk SSSR; 1985; (3):77-9. PubMed ID: 3993195
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of allopurinol on the therapeutic efficacy of methotrexate.
    Grindey GB; Moran RG
    Cancer Res; 1975 Jul; 35(7):1702-5. PubMed ID: 1131828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil.
    Schwartz PM; Dunigan JM; Marsh JC; Handschumacher RE
    Cancer Res; 1980 Jun; 40(6):1885-9. PubMed ID: 7371020
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian variation of 5-fluorouracil and cis-platinum toxicity in mice.
    Shakil A; Hirabayashi N; Toge T
    Hiroshima J Med Sci; 1993 Dec; 42(4):147-54. PubMed ID: 8014066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on intraperitoneal sequential MTX/5-FU therapy for peritoneal seeding in comparison with intravenous administration].
    Maruyama M; Takamatsu S; Sugano N; Ebuchi M; Endo M; Yuasa Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2131-6. PubMed ID: 9388524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
    Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of uridine treatment in mice on the protection of gastrointestinal toxicity caused by 5-fluorouracil.
    Bagrij T; Kralovanszky J; Gyergyay F; Kiss E; Peters GJ
    Anticancer Res; 1993; 13(3):789-93. PubMed ID: 8317913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosides.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1980 Jan; 64(1):69-72. PubMed ID: 6928048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.